Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Alnylam Pharmaceuticals Inc (ALNY)

  • Business News
  • Sept. 08, 2025, 20:16 UTC

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

Full text
Register to leave comments
There are no comments here yet...

Search

News categories

  • Technical Exchange News(9979)
  • Event(412)
  • SEC News(169140)
  • FDA Approval(9386)
  • Company Report(721)
  • Business News(112722)
© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin